SCHEMBL4884042

SCHEMBL4884042

COc1ccc(C(=Cc2c(Cl)cncc2Cl)OC(=O)Nc2ccc(C(C)C)cc2)cc1OC

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4D Q08499 6/20 0.49
PDE4A P27815 3/20 0.43
PDE4B Q07343 3/20 0.43
PDE4C Q08493 3/20 0.43
ALDH1A1 P00352 4/20 0.42
MEN1 O00255 3/20 0.42
KMT2A Q03164 3/20 0.42
PKM P14618 1/20 0.42
CYP2B6 P20813 1/20 0.40
SMN1; SMN2 Q16637 2/20 0.39
USP2 O75604 1/20 0.39
GAA P10253 1/20 0.39
TSHR P16473 1/20 0.39
CYP1A2 P05177 1/20 0.39
MAPK1 P28482 1/20 0.39
CYP2C19 P33261 1/20 0.39
LMNA P02545 1/20 0.39
HTR2A P28223 1/20 0.39
HTR2C P28335 1/20 0.39
NPC1 O15118 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4884027 1.00 PDE4D (0.49) PDE4DPDE4APDE4BPDE4CALDH1A1
SCHEMBL4880751 0.89 PDE4D (0.52) PDE4DPDE4APDE4BPDE4CALDH1A1
SCHEMBL4880746 0.89 PDE4D (0.52) PDE4DPDE4APDE4BPDE4CALDH1A1
SCHEMBL1031080 0.78 PDE4D (0.46) PDE4DPDE4APDE4BPDE4CALDH1A1
SCHEMBL1081987 0.78 PDE4D (0.46) PDE4DPDE4APDE4BPDE4CALDH1A1
SCHEMBL1029901 0.78 PDE4D (0.51) PDE4DPDE4APDE4BPDE4CALDH1A1
SCHEMBL1029900 0.78 PDE4D (0.51) PDE4DPDE4APDE4BPDE4CALDH1A1
SCHEMBL1027684 0.78 PDE4D (0.47) PDE4DPDE4APDE4BPDE4CALDH1A1
SCHEMBL4881516 0.77 ALDH1A1 (0.48) PDE4DPDE4APDE4BPDE4CALDH1A1
SCHEMBL4881513 0.77 ALDH1A1 (0.48) PDE4DPDE4APDE4BPDE4CALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080015226-A1 Derivatives of 1-phenyl-2-pyridynyl alkylene alcohols as phosphodiesterase inhibitors CHIESI FARMACEUTICI S.P.A.. 2008-01-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080015226-A1 Derivatives of 1-phenyl-2-pyridynyl alkylene alcohols as phosphodiesterase inhibitors PDE4A, PDE4B, PDE12 PDE4D 9/4885PDE4A 1/4885PDE4B 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.